Below are transactions completed by BroadOak bankers at previous firms.
Sale of In Vitro Technologies, Inc to Celsis International Plc.
Acquisition of sales and marketing rights to EpiPen in Canada from Allerex Laboratory.
Acquisition of Control Delivery Systems.
Sale of NovaScreen Biosciences to Caliper Life Sciences.
Merger with xtrana.
Sale of high content screening instrumentation company to BD Biosciences.
Sale of Sybron Biochemical Division to Novozymes.
Sale of publicly traded medical device company to Gyrus Group.
Sale of Munich based medical device company to ResMed.
Implementation of Shareholders Rights Plan.
Acquisition of publicly traded drug discovery tools company LJL BioSystems.